Table 3.
Estimated number of users per 10 000 population with an acute presentation of an NCD
| Country | Adults with hypertensive urgency | Adults with hypertensive emergency | Adult with hypertension | Adults with severe hyperglycaemia | Adults with severe hypoglycaemia | Children with severe hyperglycaemia | Children with severe hypoglycaemia | Adults with acute MI | Adults with acute stroke | Adults with heart failure | Adults with asthma attacks | Children with asthma attacks | Adults with COPD exacerbation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bangladesh | 11 | 4 | 15 | 41 | 105 | 1 | 1 | 16 | 9 | 6 | 6 | 8 | 25 |
| Central African Republic | 9 | 3 | 12 | 28 | 71 | 1 | 1 | 15 | 13 | 5 | 7 | 10 | 19 |
| Egypt | 11 | 4 | 15 | 31 | 79 | 1 | 1 | 16 | 10 | 6 | 8 | 8 | 27 |
| Guinea | 9 | 3 | 12 | 30 | 77 | 1 | 1 | 13 | 12 | 5 | 7 | 10 | 19 |
| Indonesia | 11 | 4 | 15 | 30 | 78 | 1 | 1 | 11 | 13 | 6 | 8 | 7 | 29 |
| Iraq | 9 | 3 | 12 | 45 | 116 | 1 | 1 | 16 | 9 | 5 | 7 | 10 | 19 |
| Jordan | 10 | 4 | 14 | 71 | 183 | 1 | 1 | 16 | 9 | 6 | 8 | 8 | 21 |
| Lebanon | 13 | 5 | 18 | 59 | 152 | 1 | 1 | 16 | 9 | 7 | 9 | 6 | 35 |
| Liberia | 9 | 3 | 12 | 30 | 78 | 1 | 1 | 13 | 11 | 5 | 7 | 10 | 18 |
| Philippines | 10 | 4 | 14 | 26 | 68 | 1 | 1 | 11 | 13 | 6 | 9 | 9 | 64 |
| Sierra Leone | 9 | 3 | 12 | 33 | 86 | 1 | 1 | 13 | 12 | 5 | 7 | 10 | 18 |
| Syrian Arab Republic | 10 | 4 | 14 | 50 | 130 | 1 | 1 | 16 | 9 | 6 | 7 | 9 | 21 |
| Turkey | 12 | 4 | 16 | 46 | 119 | 1 | 1 | 16 | 9 | 7 | 9 | 7 | 26 |
| Ukraine | 14 | 5 | 19 | 56 | 145 | 1 | 1 | 23 | 32 | 8 | 7 | 4 | 47 |
Acute NCD presentations include acute coronary syndrome, acute stroke, acute heart failure, hypertensive urgency/emergency, acute severe hyperglycaemia or hypoglycaemia, COPD exacerbation, asthma exacerbation.
COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; NCD, non-communicable disease.